Form 4 for GILD Gilead Sciences
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-26 · accession 0001629885-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-01 | 2025-11-26+ | GILD | Kramer Kelly A. | Dir | S - Sale+OE | $127.11 | -5,611 | 1,339 | -81% | -$713.2K |
| DM | 2025-12-01 | 2025-11-26+ | GILD | Kramer Kelly A. | Dir | M - OptEx | $81.00 | +5,611 | 4,144 | New | +$454.5K |
| DM | 2025-12-01 | 2025-11-26+ | GILD | Kramer Kelly A. | Dir | M - OptEx | $0.00 | -5,611 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-26 | S | D | 2,806 | $127.11 | 1,339 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-28 | S | D | 2,805 | $127.10 | 1,339 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-26 | M | A | 2,806 | $81.00 | 4,145 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-28 | M | A | 2,805 | $81.00 | 4,144 | D | — | — | |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-11-26 | M | D | 2,806 | $0.00 | 2,805 | D | $81.00 · — to 2026-08-19 | 2,806 Common Stock | (F2) Options vest quarterly over the first year of service and were fully vested on August 19, 2017. |
| 6 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-11-28 | M | D | 2,805 | $0.00 | 0 | D | $81.00 · — to 2026-08-19 | 2,805 Common Stock | (F2) Options vest quarterly over the first year of service and were fully vested on August 19, 2017. |